Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Cerity Partners LLC

Cerity Partners LLC boosted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,405 shares of the biotechnology company’s stock after acquiring an additional 901 shares during the period. Cerity Partners LLC’s holdings in Axon Enterprise were worth $2,171,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. boosted its holdings in shares of Axon Enterprise by 11.7% in the 1st quarter. BlackRock Inc. now owns 8,329,479 shares of the biotechnology company’s stock valued at $1,872,883,000 after buying an additional 870,481 shares in the last quarter. Capital International Investors boosted its holdings in shares of Axon Enterprise by 605.2% in the 1st quarter. Capital International Investors now owns 2,660,634 shares of the biotechnology company’s stock valued at $366,449,000 after buying an additional 2,283,343 shares in the last quarter. Sands Capital Management LLC boosted its holdings in shares of Axon Enterprise by 31.1% in the 3rd quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company’s stock valued at $519,823,000 after buying an additional 619,179 shares in the last quarter. State Street Corp boosted its holdings in shares of Axon Enterprise by 12.6% in the 1st quarter. State Street Corp now owns 2,377,095 shares of the biotechnology company’s stock valued at $534,484,000 after buying an additional 266,465 shares in the last quarter. Finally, Wellington Management Group LLP boosted its holdings in shares of Axon Enterprise by 3.3% in the 3rd quarter. Wellington Management Group LLP now owns 1,956,022 shares of the biotechnology company’s stock valued at $389,229,000 after buying an additional 62,324 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Down 1.3 %

Shares of Axon Enterprise stock opened at $293.61 on Friday. The company has a market cap of $22.16 billion, a P/E ratio of 127.65 and a beta of 0.93. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. Axon Enterprise, Inc. has a one year low of $175.37 and a one year high of $329.87. The firm has a fifty day moving average of $300.87 and a two-hundred day moving average of $257.97.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.29. The company had revenue of $432.14 million during the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. On average, analysts forecast that Axon Enterprise, Inc. will post 2.44 earnings per share for the current year.

Wall Street Analysts Forecast Growth

AXON has been the subject of several research analyst reports. JPMorgan Chase & Co. upped their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. JMP Securities increased their price target on shares of Axon Enterprise from $250.00 to $285.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 6th. TheStreet cut shares of Axon Enterprise from a “b” rating to a “c+” rating in a research note on Tuesday, February 27th. Argus initiated coverage on shares of Axon Enterprise in a research note on Wednesday, March 13th. They set a “buy” rating and a $380.00 price target for the company. Finally, Needham & Company LLC increased their price target on shares of Axon Enterprise from $315.00 to $400.00 and gave the stock a “buy” rating in a research note on Wednesday, April 10th. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $312.64.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.